Patents Assigned to Cardiac Pacemarkers, Inc.
-
Patent number: 9393426Abstract: Approaches to rank potential left ventricular (LV) pacing vectors are described. Early elimination tests are performed to determine the viability of LV cathode electrodes. Some LV cathodes are eliminated from further testing based on the early elimination tests. LV cathodes identified as viable cathodes are tested further. Viable LV cathode electrodes are tested for hemodynamic efficacy. Cardiac capture and phrenic nerve activation thresholds are then measured for potential LV pacing vectors comprising a viable LV cathode electrode and an anode electrode. The potential LV pacing vectors are ranked based on one or more of the hemodynamic efficacy of the LV cathodes, the cardiac capture thresholds, and the phrenic nerve activation thresholds.Type: GrantFiled: October 22, 2014Date of Patent: July 19, 2016Assignee: Cardiac Pacemarkers, Inc.Inventors: Krzysztof Z. Siejko, Shibaji Shome, Jiang Ding
-
Patent number: 9242107Abstract: An implantable pulse generator includes a core assembly, a seal plug, and an outer layer overmolded over the core assembly adjacent the seal plug. The core assembly defines a core hole extending through the core assembly from a core interior to a core outer surface. The core hole has a hole outer portion and a hole inner portion. A first diameter of the hole outer portion is less than a second diameter of the hole inner portion. The seal plug is positioned in the core hole and has a plug outer portion aligned with the hole outer portion and a plug inner portion aligned with the hole inner portion. A third diameter of the plug outer portion is less than a fourth diameter of the plug inner portion. The outer layer leaves a top of the seal plug exposed.Type: GrantFiled: June 19, 2014Date of Patent: January 26, 2016Assignee: Cardiac Pacemarkers, Inc.Inventors: Daragh Nolan, James M. English, John O'Rourke, Sean Walsh
-
Patent number: 9242099Abstract: A cardiac rhythm management system selects one of multiple electrodes associated with a particular heart chamber based on a relative timing between detection of a depolarization fiducial point at the multiple electrodes, or based on a delay between detection of a depolarization fiducial point at the multiple electrodes and detection of a reference depolarization fiducial point at another electrode associated with the same or a different heart chamber. Subsequent contraction-evoking stimulation therapy is delivered from the selected electrode.Type: GrantFiled: November 26, 2013Date of Patent: January 26, 2016Assignee: Cardiac Pacemarkers, Inc.Inventors: Jiang Ding, Julio C. Spinelli, Andrew P. Kramer
-
Patent number: 9242113Abstract: This document discusses, among other things, a modular antitachyarrhythmia therapy system. In an example, a modular antitachyarrhythmia system includes at least two separate modules that coordinate delivery an antitachyarrhythmia therapy, such as defibrillation therapy. In another example, a modular antitachyarrhythmia therapy system includes a sensing module, an analysis module, and a therapy module.Type: GrantFiled: March 5, 2015Date of Patent: January 26, 2016Assignee: CARDIAC PACEMARKERS, INC.Inventors: Joseph M. Smith, Richard Milton Dujmovic, Jr.
-
Patent number: 8983626Abstract: Various embodiments concern wrapping a stimulation cuff around a nerve. The cuff can comprise a main body and at least one electrode. The main body can comprise an inner tab, an outer tab, and an intermediate portion extending between the inner tab and the outer tab, the at least one electrode disposed on the intermediate portion, the main body biased such that the cuff assumes the coiled arrangement. The cuff can be uncoiled by pulling on a first elongate element attached to a first tubular member, the first tubular member encircled within the cuff. The nerve can be engaged with an inner surface of the main body along the intermediate portion while the inner tab is releaseably attached to the first elongate element. The first elongate element can be released to allow the cuff to wrap around the nerve.Type: GrantFiled: December 27, 2013Date of Patent: March 17, 2015Assignee: Cardiac Pacemarkers, Inc.Inventors: Paul E. Zarembo, Bruce A. Tockman
-
Patent number: 8116865Abstract: This document discusses, among other things, techniques for generating and delivering a high voltage defibrillation shock using an implantable cardiac rhythm management device. An output energy delivery bridge can be programmed to provide desired shock vectors or polarities. A bootstrapped fully solid-state switch control voltage generation circuit is described. Automatic polarity or vector reconfiguration embodiments are described, such as in response to an unsuccessful attempt to convert the heart to a normal rhythm.Type: GrantFiled: December 11, 2008Date of Patent: February 14, 2012Assignee: Cardiac Pacemarkers, Inc.Inventors: William J. Linder, Hari Sree
-
Patent number: 7996086Abstract: A method for operating a cardiac pacemaker in which the mode of operation of the pacemaker is altered in response to detecting an episode of atrial tachycardia. In accordance with the invention, the pacemaker's pacing mode is altered in a manner that attempts to maintain hemodynamic stability during the atrial tachycardia. Such a mode switch is particularly applicable to pacemaker patients suffering from some degree of congestive heart failure.Type: GrantFiled: September 27, 2010Date of Patent: August 9, 2011Assignee: Cardiac Pacemarkers, Inc.Inventors: Jeffrey E. Stahmann, Andrew P. Kramer